Long Covid risk no lower with those with vaccine and breakthrough infection

reuters.com

13 points·cwwc··6 comments

The headline is misleading. It's not inaccurate, but just misleading.

Long COVID risk is lower at the same rate as short COVID risk is lower for those who have received the vaccine.

In other words, by getting the vaccine you have a substantially lower long COVID risk.

Specifically, the HN submitted headline. The article headline is "Long COVID risk no lower with breakthrough infection; COVID-19 survival improves for European cancer patients." I don't believe it was a later change given the submitted url matches.

So this is one is fully on the submitter here. How brazen.

The headline is one of the worse headlines i have seen from Reuters in quite some time.

Also, short COVID risk is that a new concept ?

It's not Reuters, but the submitter.

Current Reuter's headline: Long COVID risk no lower with breakthrough infection; COVID-19 survival improves for European cancer patients

Current url: Current submitted url: https://www.reuters.com/business/healthcare-pharmaceuticals/...

The agreement between the submitted url and current headline make me believe the HN submitter intentionally edited the submission title.

(It's not entirely impossible the submitter is innocent in this, but it would require a rather specific sequence of events and some seriously unfortunate timing.)

Odd timing for releasing stories like this, as the pressure is being put on the last few vaccine holdouts.

Or is it preparation for some other Covid precautions?

You've been taken in by the submitter's editing of the article's real title. This applies specifically to breakthrough infections. Vaccines do a great job of preventing COVID in the first place, which naturally includes long COVID.

Reply on news.ycombinator.com